Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1977-10-03
1980-02-05
Sebastian, Leland A.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
206569, 260435R, 2605025, A61K 4300
Patent
active
041872843
ABSTRACT:
This invention relates to a novel diagnostic kit for use in radiographic bone scanning. More particularly, it relates to a kit comprising ingredients employed in the preparation of an intravenous injection of a complex of Technetium-99m, stannous ion, and an organic phosphonate identified as triethylene tetramine hexa (methylene phosphonic acid).
REFERENCES:
patent: 3832393 (1974-08-01), Krueger et al.
patent: 3974268 (1976-08-01), Subramanian et al.
patent: 3983227 (1976-09-01), Tofe et al.
patent: 4017595 (1977-04-01), Subramanian et al.
Moedritzer et al., J. Org. Chem., 31 (1966), pp. 1603-1607.
Subramanian et al., Radiopharmaceuticals, Society of Nuclear Medicine, Inc., N.Y., 1975, pp. 319-328.
Nadeau Jacques A.
Rolleston Richard E.
Anderson, Jr. Rudolph J.
Arther Thomas E.
Merck & Co. , Inc.
Monaco Mario A.
Sebastian Leland A.
LandOfFree
Skeletal imaging kit utilizing triethylene tetramine hexa (methy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Skeletal imaging kit utilizing triethylene tetramine hexa (methy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Skeletal imaging kit utilizing triethylene tetramine hexa (methy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2180398